Covid-19: West Bengal to ramp up the production of Hydroxychloroquine
Team Udayavani, Apr 11, 2020, 9:34 AM IST
As the COVID-19 spreads across the world, there has been a demand for an anti-malarial and anti-inflammatory drug called hydroxychloroquine. Now, the authorities in West Bengal are looking to ramp up the production of hydroxychloroquine to meet its high demand.
The only public sector unit that manufactures anti-malarial drug in India is Bengal Chemicals and Pharmaceuticals Limited. The company will also apply for a license soon from the Drugs Controller General of India to produce HCQ.
The company is said to be founded by Acharya Prafulla Chandra Ray, father of Indian chemistry. He had started HCQ’s production but stopped decades ago.
Well, Indian Council of Medical Research (ICMR) has said that it won’t recommend HCQ medicine for Covid-19 patients unless there are satisfactory results.
India manufactures 70% of the world’s supply of hydroxychloroquine. The country has a production capacity of 40 tons of hydroxychloroquine (HCQ) every month, implying 20 crore tablets of 200 mg each.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Why crime rate against Dalits increasing in MP: Cong jabs PM Modi
Indian embassy urges caution for non-essential travel to UAE amid historic flooding
PM Modi accuses previous governments of deceiving SC, ST, OBCs in the guise of social justice at Amroha rally
Nadda says Rahul Gandhi believes in dynastic rule
Sanjay Singh warns of conspiracy against Kejriwal, fears for his safety in jail
MUST WATCH
Latest Additions
Why crime rate against Dalits increasing in MP: Cong jabs PM Modi
Indian embassy urges caution for non-essential travel to UAE amid historic flooding
Kullur: Pedestrian killed in road accident
PM Modi accuses previous governments of deceiving SC, ST, OBCs in the guise of social justice at Amroha rally
Nadda says Rahul Gandhi believes in dynastic rule